Hepatocellular carcinoma (LIHC) is one of the most common primary malignant liver tumors worldwide. The RAD52 motif-containing protein 1 (RDM1) has been shown to play a role in mediating DNA damage repair and homologous recombination. This study was designed to determine the expression of RDM1 and its prognostic value as well as its relationship with immune infiltration in LIHC patients.

中文翻译：

---

RDM1基因与肝细胞癌免疫浸润及临床预后的相关性分析

肝细胞癌（LIHC）是全球最常见的原发性恶性肝肿瘤之一。已显示含有 RAD52 基序的蛋白 1 (RDM1) 在介导 DNA 损伤修复和同源重组中发挥作用。本研究旨在确定 RDM1 的表达及其预后价值以及它与 LIHC 患者免疫浸润的关系。